Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab

July 2023 | Volume 22 | Issue 7 | 685 | Copyright © July 2023


Published online June 14, 2023

doi:10.36849/JDD.7196.  

Eric Sanfilippo BSa, Adrianna Gonzalez Lopez MDb, Karl M. Saardi MDa,b

aGeorge Washington University, School of Medical and Health Sciences, Washington, DC
bGeorge Washington University, Medical Faculty Associates, Washington, DC

Abstract
Bullous pemphigoid (BP) is an autoimmune blistering disease that typically presents with pruritic, tense bullae in elderly patients.1 Several recognized presentations deviate from the classic bullous eruption, and erythrodermic BP, in particular, is thought to be a rare phenomenon. Herein, we present a case of erythrodermic BP in an African American male who initially presented with erythroderma in the absence of tense bullae. There have been no reports on erythrodermic BP in skin of color to our knowledge. The patient rapidly improved after treatment was started with dupilumab. He developed classic tense bullae seen in BP once dupilumab was discontinued.

Sanfilippo E, Gonzalez Lopez A, Saardi KM. Erythrodermic bullous pemphigoid in skin of color treated with dupilumab. J Drugs Dermatol. 2023;22(7):685-686. doi:10.36849/JDD.7196.

 

CASE REPORT

An African American male in his 80s with a past medical history of atrial fibrillation, congestive heart failure, type 2 diabetes mellitus, hypertension, prostate cancer, chronic kidney disease, and a previous cerebrovascular accident presented with complaints of a pruritic rash on his neck, chest, abdomen, arms, and groin for two weeks. He was given topical clotrimazole-betamethasone ointment by his primary care provider which was ineffective. Skin examination was significant for erythematous to brown scaly plaques arranged in a vertical linear and reticulated distribution throughout his entire chest, back, abdomen, flanks, groin, and proximal thighs (Figures 1-3). 

Additionally, there were a few pink oval plaques scattered on his forearms and a hyperpigmented patch on the right neck. An initial punch biopsy of the right shoulder yielded findings of subacute spongiotic and psoriasiform dermatitis with areas of confluent parakeratosis and eosinophils. The exam and biopsy were consistent with contact dermatitis or a drug-induced psoriasiform eruption. The patient was started on topical triamcinolone ointment and an oral prednisone taper. The patient's pruritus improved on the oral steroids; however, taper had to be stopped after 2 days due to a severe increase in his blood glucose levels. He was re-evaluated in dermatology clinic and a second punch biopsy was sent for direct immunofluorescence (DIF). At that time, he was started on dupilumab injections given recurrent pruritus, as well as clobetasol ointment. Immunofluorescence studies demonstrated IgG and IgA deposition on the epidermal side and C3 deposition on the dermal side, consistent with BP. The patient experienced significant improvement in pruritus and skin appearance and agreed to continue the dupilumab